Ledger.Open graph →
SEC Form D · filed April 9, 2024

Avalo Therapeutics, Inc

Offering
$200.0M
Sold
$130.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ROCKVILLE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Christopher Sullivan · Winter Park, FLExecJune Almenoff, M.D., Ph.D · Rockville, MDDirectorMitchell Chan · Rockville, MDDirectorJonathan Goldman, M.D · Rockville, MDDirectorAaron Kantoff · NEW YORK, NYDirectorGilla Kaplan, Ph.D · Carlsbad, CADirectorMagnus Persson, M.D., Ph.D · San Francisco, CADirectorSamantha Truex · Rockville, MDDirectorGarry Neil, M.D · Rockville, MDExec · DirectorJune Almenoff, M.D., Ph.D · Rockville, MDDirectorMitchell Chan · Rockville, MDDirectorJonathan Goldman, M.D · Rockville, MDDirectorAaron Kantoff · NEW YORK, NYDirectorGilla Kaplan, Ph.D · Carlsbad, CADirectorMagnus Persson, M.D., Ph.D · Rockville, MDDirectorSamantha Truex · Rockville, MDDirectorChristopher Sullivan · Centennial, COExecGarry Neil, M.D · Rockville, MDExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗